These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

798 related items for PubMed ID: 26339409

  • 1. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
    Sun X, Yang Z, Zhang Y, He J, Wang F, Su P, Han J, Song Z, Fei Y.
    Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
    [Abstract] [Full Text] [Related]

  • 2. Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy.
    Sun X, Liu Z, Yang Z, Xiao L, Wang F, He Y, Su P, Wang J, Jing B.
    Diagn Pathol; 2013 Dec 18; 8():208. PubMed ID: 24350576
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S, Yi XM, Zhou WQ, Cheng W, Ge JP, Zhang ZY.
    Int J Clin Exp Pathol; 2015 Dec 18; 8(11):14335-44. PubMed ID: 26823749
    [Abstract] [Full Text] [Related]

  • 4. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z, Zhang Y, Zhang X, Zhang M, Liu H, Zhang S, Qi B, Sun X.
    Biomed Pharmacother; 2015 Oct 18; 75():153-8. PubMed ID: 26422796
    [Abstract] [Full Text] [Related]

  • 5. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M, Shen D, Wang W, Xian J.
    Int J Clin Exp Pathol; 2015 Oct 18; 8(5):5542-8. PubMed ID: 26191262
    [Abstract] [Full Text] [Related]

  • 6. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y, Zhang G, Li H, Han L, Fu A, Zhang N, Zheng Y.
    Biomed Pharmacother; 2015 Oct 18; 75():185-90. PubMed ID: 26337230
    [Abstract] [Full Text] [Related]

  • 7. Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.
    Guan Y, Wu Y, Liu Y, Ni J, Nong S.
    Prostate; 2016 Aug 18; 76(11):986-93. PubMed ID: 27040772
    [Abstract] [Full Text] [Related]

  • 8. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL, Chen LM, Wang WM, Zhang LM.
    Diagn Pathol; 2015 Apr 29; 10():45. PubMed ID: 25924779
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
    Daniunaite K, Dubikaityte M, Gibas P, Bakavicius A, Rimantas Lazutka J, Ulys A, Jankevicius F, Jarmalaite S.
    Hum Mol Genet; 2017 Jul 01; 26(13):2451-2461. PubMed ID: 28398479
    [Abstract] [Full Text] [Related]

  • 10. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L, Jiang R, Li J, Wang B, Ma C, Lv Y, Mu N.
    Ann Clin Biochem; 2017 Jan 01; 54(1):127-133. PubMed ID: 27166306
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
    Fan Y, Fan J, Huang L, Ye M, Huang Z, Wang Y, Li Q, Huang J.
    Int J Clin Exp Pathol; 2015 Jan 01; 8(4):4132-7. PubMed ID: 26097603
    [Abstract] [Full Text] [Related]

  • 12. Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer.
    Kulda V, Topolcan O, Kucera R, Kripnerova M, Srbecka K, Hora M, Hes O, Klecka J, Babuska V, Rousarova M, Benson V, Pesta M.
    Anticancer Res; 2016 Sep 01; 36(9):4787-93. PubMed ID: 27630329
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
    Zhang X, Wang Y, Ning Y.
    Urol Oncol; 2017 Mar 01; 35(3):111.e15-111.e23. PubMed ID: 27856181
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of transformer 2β expression in prostate cancer.
    Diao Y, Wu D, Dai Z, Kang H, Wang Z, Wang X.
    Int J Clin Exp Pathol; 2015 Mar 01; 8(6):6967-73. PubMed ID: 26261585
    [Abstract] [Full Text] [Related]

  • 15. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L, Cai X.
    Diagn Pathol; 2014 Dec 31; 9():1000. PubMed ID: 25552204
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
    Lin ZY, Huang YQ, Zhang YQ, Han ZD, He HC, Ling XH, Fu X, Dai QS, Cai C, Chen JH, Liang YX, Jiang FN, Zhong WD, Wang F, Wu CL.
    Int J Cancer; 2014 Aug 01; 135(3):541-50. PubMed ID: 24382668
    [Abstract] [Full Text] [Related]

  • 17. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P, Padilla D, Villarejo P, Palomino T, Nieto P, Menéndez JM, Rodríguez-Montes JA.
    J Surg Oncol; 2013 Nov 01; 108(6):369-73. PubMed ID: 23970420
    [Abstract] [Full Text] [Related]

  • 18. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W, Zhao ZY, Shi L, Yuan WD.
    Diagn Pathol; 2015 Jul 21; 10():116. PubMed ID: 26194657
    [Abstract] [Full Text] [Related]

  • 19. High-Level Expression of microRNA-21 in Peripheral Blood Mononuclear Cells Is a Diagnostic and Prognostic Marker in Prostate Cancer.
    Huang W, Kang XL, Cen S, Wang Y, Chen X.
    Genet Test Mol Biomarkers; 2015 Sep 21; 19(9):469-75. PubMed ID: 26247873
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
    Zidan HE, Abdul-Maksoud RS, Elsayed WSH, Desoky EAM.
    IUBMB Life; 2018 May 21; 70(5):437-444. PubMed ID: 29522280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.